Herbas VPB

Print
EN | LT
LT - TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
EN - TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 487/16
C07D 498/16
A61P 31/18
A61K 31/4985
A61K 31/5365
A61K 31/424
European patent
(11) Number of the document 3548493
(13) Kind of document T
(96) European patent application number 17817547.7
Date of filing the European patent application 2017-11-30
(97) Date of publication of the European application 2019-10-09
(45) Date of publication and mention of the grant of the patent 2020-11-18
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/063831
Date 2017-11-30
PCT application publication
(87) Number WO 2018/102485
Date 2018-06-07
Priority applications
(30) Number Date Country code
201662429470 P 2016-12-02 US
Inventors
(72)
GRAHAM, Thomas, H., US
YU, Tao, US
ZHANG, Yonglian, US
MCCAULEY, John, A., US
Grantee
(73) Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Title
(54) TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
  TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
Last update date 2021-06-02